查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1449250

埃索美拉唑市場、佔有率、市場規模、趨勢、行業分析報告：按產品、按應用、按分銷管道、按地區、按細分市場、預測，2024-2032 年

Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球埃索美拉唑市場規模將達到287,207萬美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於胃潰瘍、胃食道逆流、佐林格-埃裡森症候群等在全球的流行，埃索美拉唑在全球醫療保健領域變得越來越重要。 埃索美拉唑在降低胃酸方面的高效功效正在推動未來幾年埃索美拉唑市場的擴張。

由於埃索美拉唑在治療過程中的廣泛應用，人們胃腸道疾病的增加表明了對埃索美拉唑的巨大需求。 2023 年的一項研究發現，感染了 COVID-19 的人當年患胃食道逆流的風險更高 (39%)，與未感染 COVID-19 病毒的人一致。感染仍在繼續。 這項研究顯示了研究期間市場的新增長機會。

市場參與者進入埃索美拉唑生產市場的出現可能會在未來幾年增加埃索美拉唑的市場規模。 例如，2023 年，Granules India Limited 的埃索美拉唑鎂緩釋膠囊（20 毫克和 40 毫克劑量）獲得美國食品和藥物管理局 (US FDA) 的簡略新藥申請 (ANDA) 批准。 這些努力預計將加強該藥物的市場供應。

製藥公司正在加強研發力度，為許多尚未解決的健康問題（包括胃潰瘍和十二指腸潰瘍）創新有效的藥物。 例如，2023年4月，Akmus Pharmaceuticals宣佈推出一款新的組合試劑盒，用於治療幽門螺旋桿菌感染和十二指腸潰瘍。 這些新興市場的發展可能會在全球創造新的埃索美拉唑市場機會。

網路存取的增加減少了世界上資訊不對稱，並促進了醫學知識的提高。 在預測期內，人口中胃部相關問題的增加可能會透過非處方藥推動市場對埃索美拉唑藥物的巨大需求。

越來越多的公司正在進入藥品生產領域，尤其是埃索美拉唑，推動了全球市場的擴張。 例如，2023年10月，Marksans獲得生產埃索美拉唑鎂膠囊的批准。

埃索美拉唑市場報告亮點

膠囊預計在未來幾年內成長最快，因為它們比片劑效果更好

由於胃酸逆流病例增加，胃食道逆流症市場佔最大市場佔有率

由於病患訪問量的增加，預計醫院和藥局部門將佔收入的更大佔有率。

由於老年人口的存在，預計亞太地區將在預測期內實現最快的成長。

目錄

簡介

  • 報告說明
    • 研究目的
    • 市場範圍
    • 假設
  • 利害關係人

第 2 章執行摘要

第3章研究方法

第4章全球埃索美拉唑市場洞察

  • 埃索美拉唑市場－通路概況
  • 埃索美拉唑市場動態
    • 推動者和機會
      • 胃腸炎病例增加推動市場發展
      • 飲食習慣的變化和肥胖的增加正在推動市場發展
    • 抑制因素和挑戰
      • 與埃索美拉唑相關的副作用可能會阻礙市場成長
  • PESTEL 分析
  • 埃索美拉唑市場通路趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球埃索美拉唑市場，依應用劃分

  • 主要發現
  • 簡介
  • 胃食道逆流病
  • 糜爛性食道炎
  • 消化性潰瘍
  • 十二指腸潰瘍
  • 佐林格-埃裡森症候群
  • 其他

第 6 章全球埃索美拉唑市場，依產品

  • 主要發現
  • 簡介
  • 膠囊
  • 平板電腦
  • 注射
  • 其他

第 7 章全球埃索美拉唑市場，依通路劃分

  • 主要發現
  • 簡介
  • 醫院和藥房
  • 網路藥局
  • 非處方藥

第 8 章全球埃索美拉唑市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年埃索美拉唑市場評估（按地區）
  • 埃索美拉唑市場 - 北美
    • 北美：埃索美拉唑市場，按應用劃分，2019-2032 年
    • 北美：埃索美拉唑市場，依通路劃分，2019-2032 年
    • 北美：埃索美拉唑市場（按產品），2019-2032 年
    • 埃索美拉唑市場—美國
    • 埃索美拉唑市場 - 加拿大
  • 埃索美拉唑市場 - 歐洲
    • 歐洲：埃索美拉唑市場，按應用劃分，2019-2032 年
    • 歐洲：埃索美拉唑市場，依通路劃分，2019-2032 年
    • 歐洲：埃索美拉唑市場（按產品），2019-2032 年
    • 埃索美拉唑市場 - 英國
    • 埃索美拉唑市場 - 法國
    • 埃索美拉唑市場 - 德國
    • 埃索美拉唑市場 - 義大利
    • 埃索美拉唑市場 - 西班牙
    • 埃索美拉唑市場 - 荷蘭
    • 埃索美拉唑市場 - 俄羅斯
  • 埃索美拉唑市場 - 亞太地區
    • 亞太地區：埃索美拉唑市場，依應用劃分，2019-2032 年
    • 亞太地區：埃索美拉唑市場，依分銷管道劃分，2019-2032 年
    • 亞太地區：埃索美拉唑市場，依產品，2019-2032 年
    • 埃索美拉唑市場 - 中國
    • 埃索美拉唑市場 - 印度
    • 埃索美拉唑市場 - 馬來西亞
    • 埃索美拉唑市場 - 日本
    • 埃索美拉唑市場-印度尼西亞
    • 埃索美拉唑市場-韓國
  • 埃索美拉唑市場－中東和非洲
    • 中東和非洲：埃索美拉唑市場，按應用劃分，2019-2032 年
    • 中東和非洲：埃索美拉唑市場，按分銷管道劃分，2019-2032 年
    • 中東和非洲：埃索美拉唑市場（按產品），2019-2032 年
    • 埃索美拉唑市場 - 沙烏地阿拉伯
    • 埃索美拉唑市場 - 阿拉伯聯合大公國
    • 埃索美拉唑市場 - 以色列
    • 埃索美拉唑市場 - 南非
  • 埃索美拉唑市場 - 拉丁美洲
    • 拉丁美洲：埃索美拉唑市場，按應用劃分，2019-2032 年
    • 拉丁美洲：埃索美拉唑市場，依通路劃分，2019-2032 年
    • 拉丁美洲：埃索美拉唑市場，副產品，2019-2032 年
    • 埃索美拉唑市場 - 墨西哥
    • 埃索美拉唑市場 - 巴西
    • 埃索美拉唑市場 - 阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • Actavis（US）
  • AstraZeneca AB（UK）
  • Blaskov（Columbia）
  • CQ Lummy（China）
  • KernPharm（Spain）
  • Mepha（India）
  • Mylan（US）
  • Sandoz（Switzerland）
  • Sanofi（France）
  • Saval Pharmaceutical（Chile）
  • Stada Arzneimittel AG（Germany）
  • Teva Pharmaceuticals（Israel）
Product Code: PM4436

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report "Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

Esomeprazole Market Report Highlights

Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.

Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.

Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.

APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.

The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:

Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsules
  • Tablets
  • Injections
  • Others

Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Gastroesophageal reflux disease
  • Erosive Esophagitis
  • Peptic Ulcers
  • Duodenal Ulcers
  • Zollinger-Ellison Syndrome
  • Others

Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals & Clinical Pharmacies
  • Online Pharmacies
  • OTC

Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Esomeprazole Market Insights

  • 4.1. Esomeprazole Market - Distribution Channel Snapshot
  • 4.2. Esomeprazole Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising gastroenteritis cases drives the market
      • 4.2.1.2. The changing eating patterns and rising obesity drives the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The side-effects associated with esomeprazole are likely to hinder market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Esomeprazole Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Esomeprazole Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • 5.3. Gastroesophageal reflux disease
    • 5.3.1. Global Esomeprazole Market, by Gastroesophageal reflux disease, by Region, 2019-2032 (USD Million)
  • 5.4. Erosive Esophagitis
    • 5.4.1. Global Esomeprazole Market, by Erosive Esophagitis, by Region, 2019-2032 (USD Million)
  • 5.5. Peptic Ulcers
    • 5.5.1. Global Esomeprazole Market, by Peptic Ulcers, by Region, 2019-2032 (USD Million)
  • 5.6. Duodenal Ulcers
    • 5.6.1. Global Esomeprazole Market, by Duodenal Ulcers, by Region, 2019-2032 (USD Million)
  • 5.7. Zollinger-Ellison Syndrome
    • 5.7.1. Global Esomeprazole Market, by Zollinger-Ellison Syndrome, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Esomeprazole Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 6.3. Capsules
    • 6.3.1. Global Esomeprazole Market, by Capsules, by Region, 2019-2032 (USD Million)
  • 6.4. Tablets
    • 6.4.1. Global Esomeprazole Market, by Tablets, by Region, 2019-2032 (USD Million)
  • 6.5. Injections
    • 6.5.1. Global Esomeprazole Market, by Injections, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Esomeprazole Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Esomeprazole Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinical Pharmacies
    • 7.3.1. Global Esomeprazole Market, by Hospitals & Clinical Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Online Pharmacies
    • 7.4.1. Global Esomeprazole Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. OTC
    • 7.5.1. Global Esomeprazole Market, by OTC, By Region, 2019-2032 (USD Million)

8. Global Esomeprazole Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Esomeprazole Market - North America
    • 8.3.1. North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.3.2. North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Esomeprazole Market - U.S.
      • 8.3.4.1. U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Esomeprazole Market - Canada
      • 8.3.5.1. Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.4. Esomeprazole Market - Europe
    • 8.4.1. Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Esomeprazole Market - UK
      • 8.4.4.1. UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Esomeprazole Market - France
      • 8.4.5.1. France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Esomeprazole Market - Germany
      • 8.4.6.1. Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Esomeprazole Market - Italy
      • 8.4.7.1. Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Esomeprazole Market - Spain
      • 8.4.8.1. Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Esomeprazole Market - Netherlands
      • 8.4.9.1. Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Esomeprazole Market - Russia
      • 8.4.10.1. Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.5. Esomeprazole Market - Asia Pacific
    • 8.5.1. Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Esomeprazole Market - China
      • 8.5.4.1. China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Esomeprazole Market - India
      • 8.5.5.1. India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Esomeprazole Market - Malaysia
      • 8.5.6.1. Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Esomeprazole Market - Japan
      • 8.5.7.1. Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Esomeprazole Market - Indonesia
      • 8.5.8.1. Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Esomeprazole Market - South Korea
      • 8.5.9.1. South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.6. Esomeprazole Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Esomeprazole Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Esomeprazole Market - UAE
      • 8.6.5.1. UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Esomeprazole Market - Israel
      • 8.6.6.1. Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Esomeprazole Market - South Africa
      • 8.6.7.1. South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • 8.7. Esomeprazole Market - Latin America
    • 8.7.1. Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Esomeprazole Market - Mexico
      • 8.7.4.1. Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Esomeprazole Market - Brazil
      • 8.7.5.1. Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Esomeprazole Market - Argentina
      • 8.7.6.1. Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Actavis (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca AB (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Blaskov (Columbia)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CQ Lummy (China)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. KernPharm (Spain)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mepha (India)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sandoz (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi (France)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Saval Pharmaceutical (Chile)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Stada Arzneimittel AG (Germany)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Teva Pharmaceuticals (Israel)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 42 China: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 45 India: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 48 Malaysia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 51 Japan: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 54 Indonesia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 57 South Korea: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 66 UAE: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 69 Israel: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 72 South Africa: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 75 Latin America: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 78 Mexico: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 81 Brazil: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Esomeprazole Market, by Application, 2019-2032 (USD Million)
  • Table 84 Argentina: Esomeprazole Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Esomeprazole Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Esomeprazole Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Esomeprazole Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Esomeprazole Market, by Application, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Esomeprazole Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Esomeprazole Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Esomeprazole Market